Amazole

Quick links to important sections

Amazole

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amazole

Quick Facts

Property Description
Active ingredient Omeprazole
Form Delayed-release capsules, Enteric-coated tablets
Pharmacological class Proton Pump Inhibitor (PPI)
Common use (General) Reduction of gastric acid secretion
Origin Synthetic (Substituted benzimidazole)

What is Amazole?

Amazole: What Type of Medicine is It?

Amazole is a pharmaceutical preparation containing the active ingredient Omeprazole, a highly effective synthetic compound classified as a foundational agent within the Proton Pump Inhibitor (PPI) pharmacological class. This type of medicine is designed to limit the stomach's ability to generate gastric acid, differentiating it from traditional remedies. Omeprazole is recognized for its role in acid control. Being a substituted benzimidazole derivative, Amazole is available in formulations designated for both prescription (Rx) and over-the-counter (OTC) use, depending on the dosage strength and specific country's regulatory status, which broadens patient access to this treatment.

Composition and Specialized Drug Forms

The core composition features the single active substance, Omeprazole, supplied primarily as specialized delayed-release capsules or enteric-coated tablets for oral administration. The need for these specialized dosage forms stems from the acid-sensitive nature of Omeprazole itself; the active compound is unstable and would be rapidly degraded in the stomach. The protective coating ensures the medicine safely reaches the higher pH environment of the small intestine for optimal absorption. This design characteristic is critical, as it assists in ensuring the therapeutic compound reaches its target effectively.

General Purpose of Proton Pump Inhibitors

The general function of Amazole is the profound and sustained reduction of gastric acid secretion. By targeting and deactivating the proton pumps within the stomach lining, the medicine effectively curtails the output of hydrochloric acid. This controlled acid suppression serves to alleviate the discomfort and burning sensation typical of acid-related problems, thereby establishing an environment for tissues that may have been damaged by constant exposure to stomach acid to begin the natural healing process. This mechanism facilitates relief over a 24-hour period, a key distinguishing factor of PPIs.

What side effects are possible with Amazole?

Possible Side Effects and Safety Information

The safety profile of Omeprazole (Amazole) is formally documented in regulatory texts, with adverse reactions categorized by frequency and the organ system affected. The most frequently reported effects are classified as Common (ge 1/100 to < 1/10), primarily involving the gastrointestinal system and the central nervous system. These include headache, abdominal pain, diarrhea, constipation, flatulence, and nausea/vomiting.

Less frequent effects are classified as Uncommon or Rare. Uncommon reactions (ge 1/1,000 to < 1/100) may include dizziness, insomnia, and increased liver enzymes. Rare reactions (ge 1/10,000 to < 1/1,000) involve severe hypersensitivity reactions (e.g., anaphylactic shock), leukopenia, and severe dermatological conditions such as Stevens-Johnson syndrome (SJS), which are documented as Serious Adverse Reactions.

Specific safety considerations are tied to the duration of use. Regulatory documents state that prolonged use (typically one year or more) is associated with an increased risk of bone fracture (hip, wrist, or spine) and hypomagnesemia (low magnesium levels). Furthermore, sustained acid suppression may lead to Vitamin B12 deficiency and the development of fundic gland polyps. Prior to treatment, the presence of gastric malignancy must be excluded, as symptom relief may mask underlying conditions. Safety considerations for specific populations, such as those with hepatic impairment, are also noted in official product information.

Overdose and Emergency Response

Overdose and when to seek help

This information details the officially documented signs of Amazole (Omeprazole) overdose and the actions mandated by regulatory authorities, based on recorded case reports.


Documented Overdose Manifestations

Regulatory labeling states that symptoms of overdose, typically involving high reported doses (320 mg to 900 mg), include headache, confusion, and drowsiness. Additional documented clinical manifestations are nausea, vomiting, blurred vision, diaphoresis (increased sweating), flushing, and dry mouth. Cardiovascular effects such as tachycardia (increased heart rate) have also been reported.


Official Emergency Response

Any suspected overdose requires immediate medical attention. Regulatory documents, including those from the FDA, explicitly instruct patients to contact a Poison Control Center right away if an overdose is suspected. Symptoms reported in documented cases have generally been transient, with no serious clinical outcome observed.

Management Protocol

Treatment for Omeprazole overdose is primarily symptomatic and supportive. Regulatory information confirms that no specific antidote is known. The drug is highly protein bound, which means it is not readily dialyzable and procedures like hemodialysis are unlikely to be effective in overdose management.

Therapeutic Uses of Amazole

Amazole: Main Uses and Benefits

Quick Facts: What Amazole Supports

  • Management of certain inflammatory conditions
  • Support for the maintenance of stable disease states
  • A treatment option for addressing key symptoms of chronic illness

Amazole is an approved therapeutic option used in the management of specific chronic inflammatory conditions. It is indicated for use to help control symptoms and may contribute to supporting long-term disease stability. The medication is utilized to address various symptoms associated with these conditions, potentially supporting patient comfort and general well-being.

Clinical experience suggests that when incorporated into a comprehensive treatment plan, Amazole may help maintain a more predictable course of the condition. It offers support for individuals seeking to manage their ongoing health needs.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Amazole (Omeprazole) eligibility is determined by specific rules outlined in official regulatory labeling, classifying individuals into approved, restricted, and contraindicated populations.

Eligibility and Restrictions

Category Official Regulatory Statement
Populations Allowed Adults and Geriatric patients are eligible. Pediatric use is established for infants as young as one month of age for erosive esophagitis, and for children one year and older for symptomatic GERD.
Contraindicated Groups Individuals with known hypersensitivity to omeprazole, substituted benzimidazoles, or any formulation component. Use is prohibited for patients receiving rilpivirine or nelfinavir co-treatment.
Conditional Use Patients with Hepatic Impairment (liver disease) are eligible but require caution. Use during pregnancy and breastfeeding is restricted and only recommended when the benefit justifies the potential unestablished risk.
Use Not Established Safety and effectiveness have not been established in infants younger than one month of age.

Regulatory Constraints

Official labeling mandates that gastric malignancy must be excluded before use in patients with gastric ulcer symptoms. Patients with pre-existing osteoporosis or Systemic Lupus Erythematosus (SLE) are advised for caution due to long-term risk warnings. Conversely, renal impairment does not require dose adjustment or regulatory restriction.

What should I know about interactions with other medicines?

Amazole's interaction profile is officially documented as affecting co-administered medicines through two primary pharmacokinetic pathways, leading to specific regulatory restrictions and requirements for use.

Formal Interaction Restrictions

The co-administration of Amazole with the antiretroviral Nelfinavir is officially designated as contraindicated due to the severe reduction in Nelfinavir plasma concentrations. Furthermore, the combination with the antiplatelet Clopidogrel is actively discouraged, as regulatory findings show that co-use results in a diminished anti-platelet effect that is not mitigated by separating the administration times.

Pharmacokinetic and Exposure Modification

Amazole is classified as a moderate inhibitor of the CYP2C19 enzyme. This inhibition prolongs the elimination and increases the exposure of co-administered CYP2C19 substrates, including Warfarin, Diazepam, and Phenytoin. For example, the regulatory label notes that Omeprazole increases serum levels of both Tacrolimus and Methotrexate.

Due to the reduction in gastric acidity, the absorption of specific drugs is modified. Medicines that require an acidic environment for optimal uptake, such as the antifungals Ketoconazole and Itraconazole, may experience decreased plasma levels. Conversely, the absorption and bioavailability of Digoxin are increased. Lastly, co-administration with enzyme inducers like the herbal product St John's Wort or the medicine Rifampin may officially reduce the plasma concentration of Amazole itself.

Mechanism of Action

How Amazole Works: The Mechanism of Action

Amazole functions as a selective allosteric modulator that primarily acts on [Target X] receptors located within the central nervous system. The mechanism involves non-competitive binding to a site distinct from the active binding pocket, which results in a conformational change in the receptor's structure. This specific interaction adjusts the receptor's sensitivity to its native neurotransmitter.

This altered receptor activity initiates a downstream signal dampening effect, leading to a reduction in [Secondary Messenger Y] production. This process modifies molecular steps that regulate cellular excitability and plasticity within affected neural pathways. The cumulative activity of Amazole contributes to the functional modulation of core [Pathway Z] regulatory pathways, influencing regulatory activity and supporting a shift in the homeostatic balance of the targeted neural systems.

Dosage and Administration Information

Amazole is administered orally as specialized delayed-release capsules or enteric-coated tablets, and is also supplied as a delayed-release powder for oral suspension. The medicine is typically taken once daily and is commonly scheduled for administration before a meal to optimize its systemic availability.


A core principle of usage is that the delayed-release capsules or tablets must be swallowed whole to preserve the integrity of the enteric coating, which is essential for the active substance to bypass stomach acid. Consequently, the capsules or tablets must not be crushed or chewed. For patients who cannot swallow the whole capsule, the contents (pellets) can be mixed with a small amount of an acidic food like applesauce or an appropriate liquid and consumed immediately.

Dosing and Duration Patterns

Typical dosage ranges and duration vary based on the clinical context:

  • Standard Adult Dose: Generally 20 mg to 40 mg once daily. Treatment courses for ulcers often range from 4 to 8 weeks.
  • High-Dose Regimens: For hypersecretory conditions, daily doses exceeding 80 mg require divided administration (multiple times per day).
  • Special Populations: Dose adjustment is necessary for patients with severe hepatic impairment, where a maximum daily dose of 20 mg is often advised. No dose adjustment is required for patients with renal impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Amazole

Evidence for Use in Erosive Esophagitis and GERD

The clinical evaluation for Amazole primarily relies on Randomized Controlled Trials (RCTs) examining chronic acid reflux (GERD) and tissue damage (Erosive Esophagitis or EE). These studies included adult populations and compared outcomes to placebo or other treatments. Researchers monitored outcomes related to physical discomfort, such as the healing of the esophagus lining (assessed by endoscopy) and patient-reported outcomes describing discomfort from heartburn. Findings highlighted measured rates of mucosal healing and patterns of symptom resolution. Pharmacodynamic studies reported that the use of Amazole was associated with measured changes in stomach acidity.

Evidence for Ulcer Healing and H. Pylori Management

Amazole was also studied for its role in addressing acute episodes like peptic ulcers. Research focused on monitoring the complete healing of these ulcers over intermediate follow-up durations. In combination with specific antibiotics, Amazole was evaluated for the clearance of H. pylori bacteria. Research described patterns where the multi-drug therapy was associated with measured rates of clearance. Furthermore, in studies focusing on prevention for patients on chronic pain relievers (NSAIDs), the use of Amazole was associated with a lower measured incidence of new ulcer formation.

Research Gaps and Uncertainties

Data for certain groups, including pediatric populations, remain insufficient. Follow-up durations were limited in many initial trials, meaning long-term outcomes are not fully established. Comparative evidence is also lacking for different long-term dosing strategies and for newer agents versus Omeprazole. The research provides limited insight into long-term outcomes after treatment is discontinued, and findings for some specific treatment variations were mixed within the published literature.

Frequently Asked Questions (FAQ)

Common questions about Amazole (FAQ)

Q: How long does it typically take to start feeling the effects of Amazole?

A: Official regulatory information indicates that the onset of the medicine's effect begins within one hour after you take it. The maximum effect is typically observed within two hours. However, it may take several days of use (between 1 to 4 days) before the desired therapeutic pattern is fully established.

Q: Does Amazole cause weight gain?

A: Weight changes, including both weight gain and weight loss, have been included among the rare adverse effects reported during the post-marketing surveillance of the drug. Most commonly reported side effects, however, do not involve changes to body weight.

Q: Are there any long-term side effects associated with taking Amazole?

A: Yes, official safety documents advise that the prolonged use of the medicine, generally defined as one year or more, is associated with specific safety risks. These risks include an increased possibility of bone fracture (in the hip, wrist, or spine) and low magnesium levels (hypomagnesemia). Extended use may also be associated with a vitamin B12 deficiency.

Q: Does Amazole interact with common pain relievers like ibuprofen or acetaminophen?

A: Amazole is known to interact with certain medicines by affecting the CYP2C19 liver enzyme. Official interaction warnings list specific drugs like Warfarin and Clopidogrel. Common pain relievers such as ibuprofen and acetaminophen are not typically listed in the formal interaction sections, but it is important to check official prescribing information for details on all potential interactions.

Q: Is it okay to drink coffee while taking Amazole?

A: Regulatory documents do not contain specific restrictions regarding coffee consumption while using Amazole. However, the purpose of this medicine is to reduce stomach acid, and acidic beverages like coffee may influence the conditions the medicine is intended to address.

Q: Is it normal to feel slightly nauseous when first starting Amazole?

A: Nausea, vomiting, and abdominal pain are officially documented among the most frequently reported adverse reactions observed in clinical trials. These effects are among those commonly reported in clinical trials.

Q: Can people with kidney problems use Amazole?

A: Official documentation indicates that patients with renal impairment (kidney problems) typically do not require an adjustment to their dose. However, it is noted that new or worsening kidney issues can be a sign of a rare adverse reaction to the medicine.

Q: Can I take Amazole while pregnant or breastfeeding?

A: Use during pregnancy is officially restricted and is only recommended when a potential benefit is considered to outweigh any potential, though unestablished, risk. Furthermore, the medicine is known to pass into human milk.

Q: What is the main difference between Amazole and similar drugs I see advertised?

A: Amazole, which contains the active ingredient omeprazole, is classified as a Proton Pump Inhibitor (PPI). This class of medicine is described in official sources as working by profoundly and selectively blocking the final step of acid production within the cells of the stomach lining. This mechanism is what primarily differentiates it from antacids and other acid-reducing medications.

Q: Why do some people say Amazole didn't work for them?

A: Official information acknowledges that the body's response to the drug can vary from person to person. Regulatory studies note that the medicine is processed by the CYP2C19 enzyme in the liver, and natural variations in this enzyme can result in differences in how the drug works for individuals.

Q: Is Amazole known to affect sleep?

A: Yes, regulatory safety documents list insomnia, which is difficulty sleeping, as a common adverse reaction to the medicine. Other common effects on the nervous system include dizziness and headache.

Q: What should I do if I forget to take my Amazole dose?

A: Patient guidelines describe taking a missed dose as soon as it is remembered. However, official guidance also describes skipping the missed dose and avoiding taking two at the same time if the next scheduled dose is near.

Q: Can Amazole affect the results of lab tests?

A: Regulatory documents state that use of the medicine can potentially interfere with certain lab tests. Specifically, it may cause an increase in levels of a substance called Chromogranin A (CgA), which is used in tests for neuroendocrine tumors.

Q: Are there different strengths of Amazole available?

A: Yes, official regulatory documents confirm that the medicine is available in multiple strengths for the delayed-release capsule forms. These can include 10 mg, 20 mg, and 40 mg strengths, as well as a powder for oral suspension.

Q: What is the risk of dependence or addiction with Amazole?

A: The medicine is not classified as a controlled substance and is not associated with addiction. However, regulatory reviews have observed a temporary physiological increase in acid secretion, called a 'rebound effect,' when the drug is stopped. This is not classified as dependence in the controlled substance sense.

Q: Are there known interactions between Amazole and common herbal supplements?

A: Official product information specifically identifies an interaction with the herbal product St John's Wort. This is because co-administration with that specific supplement may cause the plasma concentration of Amazole to be reduced.

Q: Does Amazole have a black box warning?

A: The 'Black Box Warning' is the most serious advisory placed on a medicine by the US Food and Drug Administration (FDA). As of the most recent regulatory documentation, Amazole does not carry a formal Black Box Warning.

Q: Can Amazole be used for conditions other than what it is approved for?

A: Health authorities conduct a formal review to approve the drug for specific uses only. Discussing use for any other condition is outside the scope of the official regulatory labeling.

Q: Can Amazole be used long-term?

A: The recommended duration of treatment for many conditions is typically short-term, such as 4 to 8 weeks. However, some regulatory-approved uses require treatment for longer periods, and these instances carry specific safety considerations, especially for use extending beyond a year.

Q: How long does Amazole stay in the body after the last dose?

A: The active substance has a short plasma half-life in the body, which is approximately 0.5 to 1 hour. However, the medicine works by binding directly to the proton pumps, meaning its effect on acid suppression is much more sustained, lasting for up to three days (72 hours).

Q: Is there a link between Amazole and mood changes?

A: Official reports of adverse reactions include rare psychiatric effects. These reports have encompassed descriptions of aggression, agitation, confusion, depression, and hallucinations.

Q: Do I need to change my diet while taking Amazole?

A: Official administration instructions generally advise that the medicine is taken before a meal. Beyond this specific timing instruction, there are no blanket mandates in regulatory documents that require a complete change in diet.

Q: What happens if I stop taking Amazole suddenly?

A: Stopping the drug can cause a temporary physiological increase in stomach acid secretion, often referred to as a 'rebound acid effect.' This may cause a temporary return or worsening of the original symptoms.

Q: Are generic versions of Amazole available?

A: Yes, official drug records confirm that various generic versions of the active ingredient (omeprazole), manufactured in different strengths, are available.

Q: Are there any known allergic reactions to Amazole?

A: The drug is contraindicated (prohibited from use) if an individual has a known hypersensitivity to the active ingredient or other related compounds. Rare but severe hypersensitivity reactions, including anaphylactic shock, have been reported in official safety documents.

Q: Can I take Amazole if I am lactose intolerant?

A: Official documentation for the composition of the medicine lists lactose as an inactive ingredient in some of the delayed-release capsule and tablet formulations.

Q: Is Amazole considered a controlled substance?

A: Official records from government drug enforcement agencies confirm that the active ingredient in Amazole is not currently classified as a controlled substance.

Q: What happens if I accidentally take two doses of Amazole?

A: Regulatory reports of accidental overdose indicate that symptoms are typically mild and reversible. These have included effects such as mild confusion, dizziness, headache, and blurred vision. Overdose is managed with supportive measures.

Q: Can older adults use Amazole?

A: Official regulatory documents confirm that geriatric patients are an eligible population for using this medicine. The rate at which the body eliminates the drug may be somewhat slower in older adults compared to younger patients.

How should Amazole be stored and disposed of?

The official regulatory requirements for Amazole (Omeprazole) detail specific storage and disposal procedures to ensure product integrity and public safety.

Storage Requirements

  • Temperature: Store at controlled room temperature, typically below 25°C or 30°C, and do not refrigerate or freeze the product.
  • Protection: The medicine must be protected from moisture and should be stored in the original container. If packaged in a bottle, keep the container tightly closed.
  • Safety: Always keep Amazole out of the sight and reach of children.

Disposal Instructions

Dispose of unused or expired product according to local requirements and established pharmaceutical take-back programs. Official guidelines prohibit discarding the medicine via wastewater or household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Amazole found in:

A-Z Index: